✦ LIBER ✦

Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials

✍ Scribed by A. Lipton*; A. Stopeck; R. von Moos; D. Henry; G. Richardson; G. Rodriguez; H. Bourgeois; C. Ke; S. Jun; R. Dansey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a prospective, randomized, do

✍ Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Incidence and outcomes of osteonecrosis

✍ J.E. Brown*; C.H. Barrios; I.J. Diel; T. Facon; K. Fizazi; T. Ibrahim; F. Saad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Results From a Phase 3 Randomized, Doubl

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

AOS13 Denosumab versus zoledronic acid f

✍ A.T. Stopeck; G. Richardson; S. Siena; A. Lipton; J. Brown; K. Fizazi; D. Henry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

AOSOP6 Results from the 2-year open-labe

✍ A.T. Stopeck; A. Lipton; M. Martín; J-J. Body; A. Paterson; G.G. Steger; K. Tonk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB